26 participants
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-09
- Start Date:
- 2012-03-31
- Completion:
- 2015-11-30
Conditions
- Acute Lymphoblastic Leukemia (ALL)
Interventions
- DRUG